Thursday, September 5, 2019

Johns Hopkins Opens New Center for Psychedelic Research

Johns Hopkins Opens New Center for Psychedelic Research

Among the first trials are psilocybin for anorexia nervosa and psilocybin for psychological distress and cognitive impairment in early Alzheimer’s disease.

No comments:

Post a Comment